Mark P Bainbridge, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi St Suite 300, Dubuque, IA 52001 Phone: 563-557-8500 Fax: 563-589-4050 |
Dr. Peter B Sakas, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-556-8332 Fax: 563-556-8334 |
Dr. Paul J Meus, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1500 Associates Dr, Dubuque, IA 52002 Phone: 563-584-4100 Fax: 563-584-4110 |
Dr. Timothy J Maiers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-556-8332 Fax: 563-556-8334 |
Dr. Ramana C Reddy, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1900 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-556-8332 Fax: 563-556-8334 |
Corey James Stotts, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1440 S Grandview Ave, Dubuque, IA 52003 Phone: 319-290-2097 |
Mosali Sanjeeva Reddy, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi St, Ste 300, Dubuque, IA 52001 Phone: 563-557-8500 Fax: 563-589-4050 |
Sudhir Koneru, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1515 Delhi St Suite 300, Dubuque, IA 52001 Phone: 563-557-8500 Fax: 563-589-4050 |
Dr. Robert L Gallogly, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1900 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-556-8332 Fax: 563-556-8334 |
News Archive
Health Care REIT, Inc. today announced that it has priced an offering of $300 million of 6.125% senior unsecured notes due April 15, 2020. The notes were priced at 99.297% of their face amount to yield 6.22%. Subject to customary closing conditions, the offering is expected to close on April 7, 2010.
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time.
The journal CHEST recently published an important update to the 2014 consensus statement by the Task Force for Mass Critical Care (TFMCC) on providing mass critical care utilizing research gained through experiencing the 2020 COVID-19 pandemic.
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced the presentation of interim results from the first Phase I/II trial of samalizumab, the company's investigational, first-in-class humanized monoclonal antibody.
› Verified 8 days ago